825 INDUSTRIAL ROAD, SAN CARLOS, CA
Market cap: $862.4M (2/09/2026)
Price: $2.60
Corporate Overview January 2026
Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
Investor Presentation
News, Underwriting Agreement, Legal Opinion
Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
Appoints Corleen Roche as Chief Financial Officer
Changes in Board, Management or Compensation
Q2
Q1
FY 2023
Q3
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRER14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence